Trials / Recruiting
RecruitingNCT06849518
Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Ballad Health · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a prospective pilot study to assess dynamic changes of plasma cell-free RNA (cfRNA) PD-L1 expression in patients with lung cancer undergoing immune checkpoint inhibitor (ICI) based therapy. Results will be correlated with radiographic assessment of immunotherapy treatment response and plasma NGS ctDNA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Circulogene liquid biopsy testing | A Circulogene liquid biopsy testing for plasma NGS ctDNA and plasma cfRNA PD-L1 expression. |
Timeline
- Start date
- 2025-02-11
- Primary completion
- 2026-03-01
- Completion
- 2027-03-01
- First posted
- 2025-02-27
- Last updated
- 2025-02-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06849518. Inclusion in this directory is not an endorsement.